Bisacodyl
NDC Package 45802-710-33

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Bisacodyl is used to treat constipation. Marketed by Perrigo New York Inc, this product is identified by NDC 45802-710 and is authorized under FDA application part334.

Identification & Billing

NDC Package Code
45802-710-33
Package Description
20 BLISTER PACK in 1 CARTON / 5 SUPPOSITORY in 1 BLISTER PACK
Product Code
45802-710
11-Digit Billing Format
45802071033
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
20 EA

Clinical Specifications

Proprietary Name
Bisacodyl
Dosage Form
-
Usage Information
Bisacodyl is used to treat constipation. It may also be used to clean out the intestines before a bowel examination/surgery. Bisacodyl is known as a stimulant laxative. It works by increasing the movement of the intestines, helping the stool to come out.

Regulatory & Marketing

Labeler Name
Perrigo New York Inc
FDA Application #
part334
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
05-06-2011
End Marketing Date
03-13-2016
Listing Expiration
03-13-2016
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (45802-710). Click a package code to view its specific billing and regulatory data.

45802-710-30
2 BLISTER PACK in 1 CARTON / 6 SUPPOSITORY in 1 BLISTER PACK
45802-710-32
10 BLISTER PACK in 1 CARTON / 5 SUPPOSITORY in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 45802-710-33 identifies a specific commercial package of 20 blister pack in 1 carton / 5 suppository in 1 blister pack of Bisacodyl, labeled by Perrigo New York Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Perrigo New York Inc on May 06, 2011. The current certification is valid through March 13, 2016.

What are the primary indications for this medication?

Bisacodyl is used to treat constipation. It may also be used to clean out the intestines before a bowel examination/surgery. Bisacodyl is known as a stimulant laxative. It works by increasing the movement of the intestines, helping the stool to come out.

How is this Perrigo New York Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 45802071033. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 20 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
45802-710-33
11-Digit CMS (5-4-2)
45802-0710-33

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.